Inventor · disambiguated record
Rongfu Wang
Also filed as: WANG RONGFU
1 granted patent·9 pending applications·0 citations·filing 2003–2023
9Inventor score
Files withMETHODIST HOSPITAL3WANG RONGFU2SHENZHEN HANKE NEW MATERIAL TECH CO LTD1SHENZHEN INNOVATION IMMUNOTECHNOLOGY CO LTD1THE METHODIST HOSPITAL SYSTEM1
Top patents by PatentIndex Score
10 records- 0159US2024082304A1Antigen-specific t cell receptors and chimeric antigen receptors, and methods of use in immune signaling modulation for cancer immunotherapyMETHODIST HOSPITAL·Filed 2023·Application pending·0 cites
- 0250US2023250149A1Antigen-specific t cell receptors and chimeric antigen receptors, and methods of use in immune signaling modulation for cancer immunotherapyMETHODIST HOSPITAL·Filed 2021·Application pending·0 cites
- 0342US2024025959A1Beclin 2 and uses thereof for treating cancer and neurodegenerative diseasesUNIV SOUTHERN CALIFORNIA·Filed 2021·Application pending·0 cites
- 0438US2016017011A1Phf20 and jmjd3 compositions and methods of use in cancer immunotherapyWANG RONGFU·Filed 2014·Application pending·0 cites
- 0535US2024234704A1Black Phosphorus Anode Electrodes, Methods For Preparing The Same, And Lithium Ion BatteriesSHENZHEN HANKE NEW MATERIAL TECH CO LTD·Filed 2022·Application pending·0 cites
- 0635US2022088221A1Self-assembled peptide nanoparticle and use thereofMETHODIST HOSPITAL·Filed 2020·Application pending·0 cites
- 0733US2019048342A1Cross-regulation of type i interferon signaling pathwaysTHE METHODIST HOSPITAL SYSTEM·Filed 2017·Application pending·0 cites
- 0828US2004141995A1MHC class I-restricted and MHC class II-restricted EBNA1 peptidesFiled 2003·Application pending·0 cites
- 0927US2016030443A1Methods and compositions for modulating regulatory t cell functionWANG RONGFU·Filed 2014·Application pending·0 cites
- 1018US10722563B2Prostate-specific tumor antigens and uses thereofSHENZHEN INNOVATION IMMUNOTECHNOLOGY CO LTD·Filed 2015·Granted Jul 28, 2020·0 cites·5 claims
Join the waitlist — get patent alerts
Get an alert when Rongfu Wang files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →